Drugs that contain Diclofenac Potassium

1. List of Cambia drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8097651 ASSERTIO Diclofenac formulations and methods of use
Jun, 2026

(3 years from now)

US7759394 ASSERTIO Diclofenac formulations and methods of use
Jun, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8927604 ASSERTIO Diclofenac formulations and methods of use
Jun, 2026

(3 years from now)

US9827197 ASSERTIO Diclofenac formulations and methods of use
Jun, 2026

(3 years from now)

Market Authorisation Date: 17 June, 2009

Treatment: Acute treatment of migraine attacks with or without aura in adults

Dosage: FOR SOLUTION;ORAL

How can I launch a generic of CAMBIA before it's patent expiration?
More Information on Dosage

2. List of Zipsor drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8623920 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

US7884095 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

US9561200 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

US8110606 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

US7662858 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

US7939518 ASSERTIO Method of treating post-surgical acute pain
Feb, 2029

(6 years from now)

Exclusivity Exclusivity Expiration
New Patient Population (NPP) May 25, 2024

Market Authorisation Date: 16 June, 2009

Treatment: Diclofenac potassium for relief of mild to moderate acute pain; Nonsteroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain

Dosage: CAPSULE;ORAL

How can I launch a generic of ZIPSOR before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic